{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:03:33Z","timestamp":1759010613149},"reference-count":42,"publisher":"American Society for Microbiology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Antibodies against the protective antigen (PA) component of anthrax toxin play an important role in protection against disease caused by<jats:named-content content-type=\"genus-species\">Bacillus anthracis<\/jats:named-content>. In this study, we examined defined combinations of PA-specific monoclonal antibodies for their ability to neutralize anthrax toxin in cell culture assays. We observed additive, synergistic, and antagonistic effects of the antibodies depending on the specific antibody combination examined and the specific assay used. Synergistic toxin-neutralizing antibody interactions were examined in more detail. We found that one mechanism that can lead to antibody synergy is the bridging of PA monomers by one antibody, with resultant bivalent binding of the second antibody. These results may aid in optimal design of new vaccines and antibody therapies against anthrax.<\/jats:p>","DOI":"10.1128\/cvi.05714-11","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T15:47:23Z","timestamp":1332517643000},"page":"731-739","source":"Crossref","is-referenced-by-count":16,"title":["Analysis of Defined Combinations of Monoclonal Antibodies in Anthrax Toxin Neutralization Assays and Their Synergistic Action"],"prefix":"10.1128","volume":"19","author":[{"given":"Miriam M.","family":"Ngundi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D.","family":"Meade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen F.","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindi R.","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drusilla L.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","published-online":{"date-parts":[[2012,3,21]]},"reference":[{"key":"key20180919073605_B1","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1084\/jem.20100995","article-title":"A requirement for FcgammaR in antibody-mediated bacterial toxin neutralization","volume":"207","author":"Abboud","year":"2010","journal-title":"J. Exp. Med."},{"key":"key20180919073605_B2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.it.2006.07.002","article-title":"Anthrax toxins: a paradigm of bacterial immune suppression","volume":"27","author":"Baldari","year":"2006","journal-title":"Trends Immunol."},{"key":"key20180919073605_B3","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1021\/ac701741s","article-title":"Detection and quantification of anthrax lethal factor in serum by mass spectrometry","volume":"79","author":"Boyer","year":"2007","journal-title":"Anal. Chem."},{"key":"key20180919073605_B4","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/CVI.00145-10","article-title":"Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assays","volume":"17","author":"Brady","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073605_B5","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1128\/IAI.72.11.6313-6317.2004","article-title":"Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies","volume":"72","author":"Brossier","year":"2004","journal-title":"Infect. Immun."},{"key":"key20180919073605_B6","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1128\/IAI.00200-09","article-title":"Novel chimpanzee\/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody","volume":"77","author":"Chen","year":"2009","journal-title":"Infect. Immun."},{"key":"key20180919073605_B7","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1128\/CVI.00174-10","article-title":"Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro","volume":"17","author":"Clement","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073605_B8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"key20180919073605_B9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.mam.2009.08.006","article-title":"Anthrax vaccination strategies","volume":"30","author":"Cybulski","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"key20180919073605_B10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4049\/jimmunol.172.2.747","article-title":"Cutting edge: anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharide","volume":"172","author":"Dang","year":"2004","journal-title":"J. Immunol."},{"key":"key20180919073605_B11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"key20180919073605_B12","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1128\/IAI.00006-11","article-title":"Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis","volume":"79","author":"Ebrahimi","year":"2011","journal-title":"Infect. Immun."},{"key":"key20180919073605_B13","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"key":"key20180919073605_B14","doi-asserted-by":"crossref","first-page":"D28","DOI":"10.1016\/j.vaccine.2009.08.102","article-title":"Advances in the development of next-generation anthrax vaccines","volume":"27","author":"Friedlander","year":"2009","journal-title":"Vaccine"},{"key":"key20180919073605_B15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1574-695X.2006.00114.x","article-title":"Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen","volume":"47","author":"Gubbins","year":"2006","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"key20180919073605_B16","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","article-title":"Anthrax as a biological weapon","volume":"281","author":"Inglesby","year":"1999","journal-title":"JAMA"},{"key":"key20180919073605_B17","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations in eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073605_B18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2008.01.007","article-title":"Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization","volume":"333","author":"Li","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"key20180919073605_B19","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14712598.7.6.843","article-title":"New insights into the pathogenesis and treatment of anthrax toxin-induced shock","volume":"7","author":"Li","year":"2007","journal-title":"Expert Opin. Biol. Ther."},{"key":"key20180919073605_B20","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect. Immun."},{"key":"key20180919073605_B21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"key20180919073605_B22","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect. Immun."},{"issue":"Pt. 3","key":"key20180919073605_B23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1099\/13500872-142-3-707","article-title":"Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies","volume":"142","author":"Little","year":"1996","journal-title":"Microbiology"},{"key":"key20180919073605_B24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1574-695X.2011.00782.x","article-title":"Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo","volume":"62","author":"Little","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"key20180919073605_B25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/IAI.00633-08","article-title":"Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model","volume":"77","author":"Loving","year":"2009","journal-title":"Infect. Immun."},{"key":"key20180919073605_B26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt0602-597","article-title":"Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity","volume":"20","author":"Maynard","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"key20180919073605_B27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mib.2003.12.001","article-title":"The roles of anthrax toxin in pathogenesis","volume":"7","author":"Moayeri","year":"2004","journal-title":"Curr. Opin. Microbiol."},{"key":"key20180919073605_B28","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/IAI.72.6.3276-3283.2004","article-title":"Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages","volume":"72","author":"Mohamed","year":"2004","journal-title":"Infect. Immun."},{"key":"key20180919073605_B29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1128\/CVI.00513-09","article-title":"Comparison of three anthrax toxin neutralization assays","volume":"17","author":"Ngundi","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073605_B30","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"Nowakowski","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"key20180919073605_B31","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"key20180919073605_B32","first-page":"358","article-title":"Biochemical characterization of murine Fc gamma RI","volume":"78","author":"Quilliam","year":"1993","journal-title":"Immunology"},{"key":"key20180919073605_B33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.2946078","article-title":"Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors","volume":"234","author":"Ravetch","year":"1986","journal-title":"Science"},{"key":"key20180919073605_B34","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1128\/IAI.01254-08","article-title":"Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed","volume":"77","author":"Reason","year":"2009","journal-title":"Infect. Immun."},{"key":"key20180919073605_B35","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect. Immun."},{"key":"key20180919073605_B36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1462-5822.2006.00840.x","article-title":"Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signalling","volume":"9","author":"Rossi Paccani","year":"2007","journal-title":"Cell. Microbiol."},{"key":"key20180919073605_B37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1086\/430708","article-title":"A phase 1 study of PAmAb, a fully human monoclonal antibody against Bacillus anthracis protective antigen, in healthy volunteers","volume":"41","author":"Subramanian","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"key20180919073605_B38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1084\/jem.150.3.580","article-title":"Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors","volume":"150","author":"Unkeless","year":"1979","journal-title":"J. Exp. Med."},{"key":"key20180919073605_B39","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1128\/CVI.00194-09","article-title":"Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays","volume":"16","author":"Verma","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073605_B40","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1128\/IAI.00712-06","article-title":"Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity","volume":"74","author":"Vitale","year":"2006","journal-title":"Infect. Immun."},{"key":"key20180919073605_B41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1128\/IAI.74.1.394-398.2006","article-title":"Immunological correlates of protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits","volume":"74","author":"Weiss","year":"2006","journal-title":"Infect. Immun."},{"key":"key20180919073605_B42","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.05714-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:47:35Z","timestamp":1627591655000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.05714-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,21]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,4,26]]},"published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1128\/CVI.05714-11"],"URL":"https:\/\/doi.org\/10.1128\/cvi.05714-11","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,21]]}}}